Stock ALVO ALVOTECH
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alvotech

Equities

ALVO

LU2458332611

End-of-day quote Nasdaq
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
13.35 USD 0.00% Intraday chart for Alvotech +0.45% +16.29%
03:57pm Alvotech Signs Commercialization Deal for Prolia, Xgeva Biosimilar MT
03:21pm Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab MT

Evolution of the average Target Price on Alvotech

Price target over the last 5 years

History of analyst recommendation changes

15a7d697aac648e46cb602de763cc821.n7CDPEtnZ88nFcJOUpgzcdJbY4VrCpZ-tRf6vdPYyOw.2YGyfxpKIopwe7UMA9ddKKIPFeE9c-MS3lui05btg7v70dFEDlcQjF96lw~a33bf67da57d0ada53a3228f91aa68e8

Analyst Recommendations on Alvotech

Barclays Raises Price Target on Alvotech to $20 From $17, Maintains Overweight Rating MT
Barclays Upgrades Alvotech to Overweight From Equalweight, Raises Price Target to $17 From $10 MT
Citigroup Upgrades Alvotech to Neutral From Sell, Adjusts Price Target to $10 From $5 MT
Barclays Initiates Alvotech With Equalweight Rating, Price Target is $10 MT
Deutsche Bank Adjusts Alvotech Price Target to $8 From $12, Maintains Hold Rating MT
Deutsche Bank Adjusts Alvotech's Price Target to $12 From $8, Maintains Hold Rating MT
Morgan Stanley Starts Alvotech at Equalweight With $10 Price Target MT
Citigroup Double Downgrades Alvotech to Sell From Buy, Adjusts Price Target to $5 From $12 MT
Citigroup Starts Alvotech at Buy With $12 Price Target MT
Deutsche Bank Initiates Coverage on Alvotech With Hold Rating, $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
13.5 USD
Average target price
16.5 USD
Spread / Average Target
+22.22%
High Price Target
28 USD
Spread / Highest target
+107.41%
Low Price Target
6 USD
Spread / Lowest Target
-55.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Alvotech

Barclays
Citigroup
Deutsche Bank Securities
Morgan Stanley

Ratings for Alvotech

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALVO Stock
  4. Consensus Alvotech